Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04494971 · ClinicalTrials.gov registry record
The PortionSize Smartphone App Pilot (PS Pilot)
A clinical trial, sponsored by Pennington Biomedical Research Center.
- Completed
- Registry status
- 15
- Enrollment target
NCT04494971: Completed study, sponsored by Pennington Biomedical Research Center.
NCT04494971 is a clinical trial that has completed, run by Pennington Biomedical Research Center. The registered enrollment target is 15 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04494971 has completed, sponsored by Pennington Biomedical Research Center.
- COMPLETED
- Registry status
- 15 participants
- Enrollment target
Study Summary
The objective is to examine the preliminary validity, reliability and perceived participant satisfaction of the PortionSize app.
Primary Outcome
Compared measurements from PortionSize to weighed values in the laboratory, which is the criterion measure.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2020-08-31 |
| Est. Completion | 2020-11-20 |
What the finished NCT04494971 record still lists
NCT04494971 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 15 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT04494971 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04494971 about?
NCT04494971 is a clinical study titled "The PortionSize Smartphone App Pilot (PS Pilot)". The objective is to examine the preliminary validity, reliability and perceived participant satisfaction of the PortionSize app.
What is the current status of trial NCT04494971?
This trial is currently completed. The enrollment target is 15 participants. The study started on 2020-08-31. Estimated completion is 2020-11-20.
Who is sponsoring clinical trial NCT04494971?
This trial is sponsored by Pennington Biomedical Research Center, which has 258 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI